 |
Prescription and Over-the-Counter Drug Product List - 22nd Edition
Cumulative Supplement Number 5: May 2002
NOTE: The format for the Monthly Additions/Deletions Drug Product List has changed as of the July Cumulative Supplement (CS) of the 21st Edition to mirror the CS. Refer to the CS Preface section CUMULATIVE SUPPLEMENT LEGEND.
ACETAMINOPHEN; CODEINE PHOSPHATE
CAPSULE; ORAL
PHENAPHEN W/ CODEINE NO. 2
>D> + ROBINS AH 325MG;15MG N84444 001 MAY DISC
>A> @ 325MG;15MG N84444 001 MAY DISC
SOLUTION; ORAL
ACETAMINOPHEN AND CODEINE PHOSPHATE
>D> AA ALPHARMA 120MG/5ML;12MG/5ML N85861 001 MAY CRLD
>A> AA + 120MG/5ML;12MG/5ML N85861 001 MAY CRLD
TYLENOL W/ CODEINE
>D> AA + JOHNSON RW 120MG/5ML;12MG/5ML N85057 001 MAY DISC
>A> @ 120MG/5ML;12MG/5ML N85057 001 MAY DISC
TABLET; ORAL
ACETAMINOPHEN AND CODEINE PHOSPHATE
>D> AA PUREPAC PHARM 300MG;60MG N86683 001 MAY DISC
>A> @ 300MG;60MG N86683 001 MAY DISC
ACETAMINOPHEN; HYDROCODONE BITARTRATE
TABLET; ORAL
NORCO
>D> AA + WATSON LABS 325MG;5MG N40099 001 JUN 25, 1997 MAY CTNA
>A> AA + 325MG;5MG N40099 001 JUN 25, 1997 MAY CTNA
AMMONIUM LACTATE
CREAM; TOPICAL
>A> AMMONIUM LACTATE
>A> AB CLAY PARK EQ 12% BASE N75774 001 MAY 01, 2002 MAY NEWA
>A> LAC-HYDRIN
>D> + WESTWOOD SQUIBB EQ 12% BASE N20508 001 AUG 29, 1996 MAY CFTG
>A> AB + EQ 12% BASE N20508 001 AUG 29, 1996 MAY CFTG
AMPRENAVIR
CAPSULE; ORAL
AGENERASE
>D> GLAXOSMITHKLINE 50MG N21007 001 APR 15, 1999 MAY DISC
>A> @ 50MG N21007 001 APR 15, 1999 MAY DISC
>D> + 150MG N21007 002 APR 15, 1999 MAY DISC
>A> @ 150MG N21007 002 APR 15, 1999 MAY DISC
SOLUTION; ORAL
>D> + GLAXOSMITHKLINE 15MG/ML N21039 001 APR 15, 1999 MAY DISC
>A> @ 15MG/ML N21039 001 APR 15, 1999 MAY DISC
AZELASTINE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC
OPTIVAR
>D> + ASTA 0.05% N21127 001 MAY 22, 2000 MAY CAHN
>A> + MURO 0.05% N21127 001 MAY 22, 2000 MAY CAHN
AZITHROMYCIN DIHYDRATE
TABLET; ORAL
ZITHROMAX
>A> + PFIZER EQ 500MG BASE N50784 001 MAY 24, 2002 MAY NEWA
BENZTROPINE MESYLATE
TABLET; ORAL
BENZTROPINE MESYLATE
>A> AA COREPHARMA 0.5MG N72264 001 FEB 27, 1989 MAY CAHN
>A> AA 1MG N72265 001 FEB 27, 1989 MAY CAHN
>A> AA 2MG N72266 001 FEB 27, 1989 MAY CAHN
>D> AA GENEVA PHARMS TECH 0.5MG N72264 001 FEB 27, 1989 MAY CAHN
>D> AA 1MG N72265 001 FEB 27, 1989 MAY CAHN
>D> AA 2MG N72266 001 FEB 27, 1989 MAY CAHN
BROMODIPHENHYDRAMINE HYDROCHLORIDE; CODEINE PHOSPHATE
SYRUP; ORAL
BROMANYL
>D> AA ALPHARMA 12.5MG/5ML;10MG/5ML N88343 001 AUG 15, 1984 MAY DISC
>A> @ 12.5MG/5ML;10MG/5ML N88343 001 AUG 15, 1984 MAY DISC
BUSPIRONE HYDROCHLORIDE
TABLET; ORAL
BUSPIRONE HCL
>A> AB MYLAN 30MG N76008 001 JUN 28, 2001 MAY CAHN
>D> AB MYLAN TECHNOLOGIES 30MG N76008 001 JUN 28, 2001 MAY CAHN
>A> AB PHARMEX PRODS 5MG N75388 001 MAY 09, 2002 MAY NEWA
>A> AB 10MG N75388 002 MAY 09, 2002 MAY NEWA
>A> AB 15MG N75388 003 MAY 09, 2002 MAY NEWA
CAPTOPRIL
TABLET; ORAL
CAPOTEN
>D> AB BRISTOL MYERS SQUIBB 12.5MG N18343 005 JAN 17, 1985 MAY CAHN
>D> AB 25MG N18343 002 MAY CAHN
>D> @ 37.5MG N18343 006 SEP 17, 1986 MAY CAHN
>D> AB 50MG N18343 001 MAY CAHN
>D> @ 75MG N18343 007 JUN 13, 1995 MAY CAHN
>D> AB + 100MG N18343 003 MAY CAHN
>D> @ 150MG N18343 004 JUN 13, 1995 MAY CAHN
>A> AB PAR PHARM 12.5MG N18343 005 JAN 17, 1985 MAY CAHN
>A> AB 25MG N18343 002 MAY CAHN
>A> @ 37.5MG N18343 006 SEP 17, 1986 MAY CAHN
>A> AB 50MG N18343 001 MAY CAHN
>A> @ 75MG N18343 007 JUN 13, 1995 MAY CAHN
>A> AB + 100MG N18343 003 MAY CAHN
>A> @ 150MG N18343 004 JUN 13, 1995 MAY CAHN
CEFADROXIL/CEFADROXIL HEMIHYDRATE
CAPSULE; ORAL
DURICEF
>D> @ BRISTOL MYERS SQUIBB EQ 250MG BASE N50512 002 MAY CAHN
>A> @ GALEN CHEM EQ 250MG BASE N50512 002 MAY CAHN
FOR SUSPENSION; ORAL
>D> BRISTOL MYERS SQUIBB EQ 125MG BASE/5ML N50527 002 MAY CAHN
>D> EQ 250MG BASE/5ML N50527 003 MAY CAHN
>D> + EQ 500MG BASE/5ML N50527 001 MAY CAHN
>A> GALEN CHEM EQ 125MG BASE/5ML N50527 002 MAY CAHN
>A> EQ 250MG BASE/5ML N50527 003 MAY CAHN
>A> + EQ 500MG BASE/5ML N50527 001 MAY CAHN
TABLET; ORAL
>D> AB + BRISTOL MYERS SQUIBB EQ 1GM BASE N50528 001 MAY CAHN
>A> AB + GALEN CHEM EQ 1GM BASE N50528 001 MAY CAHN
CEFPODOXIME PROXETIL
FOR SUSPENSION; ORAL
>A> CEFPODOXIME PROXETIL
>A> AB RANBAXY EQ 50MG BASE/5ML N65082 001 MAY 31, 2002 MAY NEWA
>A> AB EQ 100MG BASE/5ML N65082 002 MAY 31, 2002 MAY NEWA
>A> VANTIN
>D> PHARMACIA AND UPJOHN EQ 50MG BASE/5ML N50675 001 AUG 07, 1992 MAY CFTG
>A> AB EQ 50MG BASE/5ML N50675 001 AUG 07, 1992 MAY CFTG
>D> + EQ 100MG BASE/5ML N50675 002 AUG 07, 1992 MAY CFTG
>A> AB + EQ 100MG BASE/5ML N50675 002 AUG 07, 1992 MAY CFTG
CEPHALOGLYCIN
CAPSULE; ORAL
KAFOCIN
>D> + LILLY 250MG N50219 001 MAY DISC
>A> + @ 250MG N50219 001 MAY DISC
CHLORPROPAMIDE
TABLET; ORAL
CHLORPROPAMIDE
>D> AB LEDERLE 100MG N89561 001 SEP 04, 1987 MAY DISC
>A> @ 100MG N89561 001 SEP 04, 1987 MAY DISC
>D> AB 250MG N89562 001 SEP 04, 1987 MAY DISC
>A> @ 250MG N89562 001 SEP 04, 1987 MAY DISC
CLOZAPINE
TABLET; ORAL
CLOZARIL
>D> AB + NOVARTIS 25MG N19758 001 SEP 26, 1989 MAY CRLD
>A> AB 25MG N19758 001 SEP 26, 1989 MAY CRLD
>D> AB 100MG N19758 002 SEP 26, 1989 MAY CRLD
>A> AB + 100MG N19758 002 SEP 26, 1989 MAY CRLD
CYCLOSPORINE
CAPSULE; ORAL
>A> CYCLOSPORINE
>D> AB ABBOTT 25MG N65003 001 MAY 12, 2000 MAY CTEC
>A> AB1 25MG N65003 001 MAY 12, 2000 MAY CTEC
>D> 50MG N65003 002 MAY 12, 2000 MAY CTEC
>A> BX 50MG N65003 002 MAY 12, 2000 MAY CTEC
>D> AB1 100MG N65003 003 MAY 12, 2000 MAY CTEC
>A> AB1 100MG N65003 003 MAY 12, 2000 MAY CTEC
>D> AB EON 25MG N65017 002 JAN 13, 2000 MAY CTEC
>A> AB1 25MG N65017 002 JAN 13, 2000 MAY CTEC
>D> AB 100MG N65017 001 JAN 13, 2000 MAY CTEC
>A> AB1 100MG N65017 001 JAN 13, 2000 MAY CTEC
>D> AB SIDMAK LABS 25MG N65044 002 DEC 20, 2000 MAY CTEC
>A> AB1 25MG N65044 002 DEC 20, 2000 MAY CTEC
>D> AB 100MG N65044 001 DEC 20, 2000 MAY CTEC
>A> AB1 100MG N65044 001 DEC 20, 2000 MAY CTEC
>A> AB2 TORPHARM 25MG N65040 001 MAY 09, 2002 MAY CTEC
>A> AB2 100MG N65040 002 MAY 09, 2002 MAY NEWA
>D> 25MG N65040 001 MAY 09, 2002 MAY CTEC
>A> NEORAL
>D> AB NOVARTIS 25MG N50715 001 JUL 14, 1995 MAY CTEC
>A> AB1 25MG N50715 001 JUL 14, 1995 MAY CTEC
>D> AB + 100MG N50715 002 JUL 14, 1995 MAY CTEC
>A> AB1 + 100MG N50715 002 JUL 14, 1995 MAY CTEC
>A> SANDIMMUNE
>D> BX NOVARTIS 25MG N50625 001 MAR 02, 1990 MAY CTEC
>A> AB2 25MG N50625 001 MAR 02, 1990 MAY CTEC
>D> BX + 100MG N50625 002 MAR 02, 1990 MAY CTEC
>A> AB2 + 100MG N50625 002 MAR 02, 1990 MAY CTEC
DESMOPRESSIN ACETATE
SPRAY, METERED; NASAL
DDAVP
>D> AB + AVENTIS 0.01MG/SPRAY N17922 002 FEB 06, 1989 MAY DISC
>A> @ 0.01MG/SPRAY N17922 002 FEB 06, 1989 MAY DISC
DESMOPRESSIN ACETATE
>D> AB BAUSCH AND LOMB 0.01MG/SPRAY N74830 001 JAN 25, 1999 MAY CRLD
>A> AB + 0.01MG/SPRAY N74830 001 JAN 25, 1999 MAY CRLD
DESOXIMETASONE
OINTMENT; TOPICAL
DESOXIMETASONE
>D> AB ALTANA 0.25% N73440 001 APR 01, 1998 MAY DISC
>A> @ 0.25% N73440 001 APR 01, 1998 MAY DISC
>A> DIMYRISTOYL LECITHIN; PERFLEXANE
>A> INJECTABLE; INTRAVENOUS
>A> IMAGENT
>A> + ALLIANCE PHARM 0.92MG/VIAL;0.092MG/VIAL N21191 001 MAY 31, 2002 MAY NEWA
DIPHENHYDRAMINE HYDROCHLORIDE
INJECTABLE; INJECTION
DIPHENHYDRAMINE HCL
>A> AP AM PHARM PARTNERS 50MG/ML N40466 001 MAY 28, 2002 MAY NEWA
DONEPEZIL HYDROCHLORIDE
TABLET; ORAL
ARICEPT
>D> EISAI 5MG N20690 002 NOV 25, 1996 MAY CAHN
>D> + 10MG N20690 001 NOV 25, 1996 MAY CAHN
>A> EISAI MEDCL RES 5MG N20690 002 NOV 25, 1996 MAY CAHN
>A> + 10MG N20690 001 NOV 25, 1996 MAY CAHN
DOXEPIN HYDROCHLORIDE
CAPSULE; ORAL
DOXEPIN HCL
>D> AB LEDERLE EQ 10MG BASE N71685 001 JAN 05, 1988 MAY DISC
>A> @ EQ 10MG BASE N71685 001 JAN 05, 1988 MAY DISC
>D> AB EQ 25MG BASE N71686 001 JAN 05, 1988 MAY DISC
>A> @ EQ 25MG BASE N71686 001 JAN 05, 1988 MAY DISC
>D> AB EQ 50MG BASE N71673 001 JAN 05, 1988 MAY DISC
>A> @ EQ 50MG BASE N71673 001 JAN 05, 1988 MAY DISC
>D> AB EQ 75MG BASE N71674 001 JAN 05, 1988 MAY DISC
>A> @ EQ 75MG BASE N71674 001 JAN 05, 1988 MAY DISC
>D> AB EQ 100MG BASE N71675 001 JAN 05, 1988 MAY DISC
>A> @ EQ 100MG BASE N71675 001 JAN 05, 1988 MAY DISC
>D> AB EQ 150MG BASE N71676 001 JAN 05, 1988 MAY DISC
>A> @ EQ 150MG BASE N71676 001 JAN 05, 1988 MAY DISC
ENALAPRIL MALEATE
TABLET; ORAL
VASOTEC
>A> AB BIOVAIL 2.5MG N18998 005 JUL 26, 1988 MAY CAHN
>A> AB 5MG N18998 001 DEC 24, 1985 MAY CAHN
>A> AB 10MG N18998 002 DEC 24, 1985 MAY CAHN
>A> AB + 20MG N18998 003 DEC 24, 1985 MAY CAHN
>D> AB MERCK 2.5MG N18998 005 JUL 26, 1988 MAY CAHN
>D> AB 5MG N18998 001 DEC 24, 1985 MAY CAHN
>D> AB 10MG N18998 002 DEC 24, 1985 MAY CAHN
>D> AB + 20MG N18998 003 DEC 24, 1985 MAY CAHN
ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE
TABLET; ORAL
VASERETIC
>A> AB BIOVAIL 5MG;12.5MG N19221 003 JUL 12, 1995 MAY CAHN
>A> AB + 10MG;25MG N19221 001 OCT 31, 1986 MAY CAHN
>D> AB MERCK 5MG;12.5MG N19221 003 JUL 12, 1995 MAY CAHN
>D> AB + 10MG;25MG N19221 001 OCT 31, 1986 MAY CAHN
ENALAPRILAT
INJECTABLE; INJECTION
VASOTEC
>A> AP + BIOVAIL 1.25MG/ML N19309 001 FEB 09, 1988 MAY CAHN
>D> AP + MERCK 1.25MG/ML N19309 001 FEB 09, 1988 MAY CAHN
ESTRADIOL
FILM, EXTENDED RELEASE; TRANSDERMAL
ALORA
>D> BX WATSON LABS 0.025MG/24HR N20655 004 APR 05, 2002 MAY CMS1
>A> BX 0.025MG/24HR N20655 004 APR 05, 2002 MAY CMS1
ESTRADIOL; NORGESTIMATE
TABLET; ORAL
ORTHO-PREFEST
>D> + JOHNSON RW 1MG;1MG;0.09MG N21040 001 OCT 22, 1999 MAY CAHN
>A> + KING PHARMS 1MG;1MG;0.09MG N21040 001 OCT 22, 1999 MAY CAHN
ETHINYL ESTRADIOL; LEVONORGESTREL
TABLET; ORAL-21
>A> ALESSE
>D> AB + WYETH AYERST 0.02MG;0.1MG N20683 001 MAR 27, 1997 MAY CTEC
>A> AB1 + 0.02MG;0.1MG N20683 001 MAR 27, 1997 MAY CTEC
>A> PORTIA-21
>A> AB BARR 0.03MG;0.15MG N75866 001 MAY 23, 2002 MAY NEWA
TABLET; ORAL-28
>A> PORTIA-28
>A> AB BARR 0.03MG;0.15MG N75866 002 MAY 23, 2002 MAY NEWA
FLUOCINOLONE ACETONIDE
SOLUTION; TOPICAL
FLUONID
>D> AT ALLERGAN HERBERT 0.01% N87158 001 MAR 17, 1983 MAY DISC
>A> @ 0.01% N87158 001 MAR 17, 1983 MAY DISC
FLUVOXAMINE MALEATE
TABLET; ORAL
FLUVOXAMINE MALEATE
>D> AB EON 100MG N75888 003 NOV 29, 2000 MAY CRLD
>A> AB + 100MG N75888 003 NOV 29, 2000 MAY CRLD
LUVOX
>D> AB SOLVAY 25MG N20243 001 DEC 05, 1994 MAY DISC
>A> @ 25MG N20243 001 DEC 05, 1994 MAY DISC
>D> AB 50MG N20243 002 DEC 05, 1994 MAY DISC
>A> @ 50MG N20243 002 DEC 05, 1994 MAY DISC
>D> AB + 100MG N20243 003 DEC 05, 1994 MAY DISC
>A> @ 100MG N20243 003 DEC 05, 1994 MAY DISC
GRISEOFULVIN, MICROCRYSTALLINE
CAPSULE; ORAL
GRISACTIN
>D> + WYETH AYERST 250MG N50051 001 MAY DISC
>A> @ 250MG N50051 001 MAY DISC
TABLET; ORAL
>D> AB WYETH AYERST 500MG N60212 001 MAY DISC
>A> @ 500MG N60212 001 MAY DISC
GRISEOFULVIN, ULTRAMICROCRYSTALLINE
TABLET; ORAL
GRISACTIN ULTRA
>D> AB WYETH AYERST 165MG N62438 001 NOV 17, 1983 MAY DISC
>A> @ 165MG N62438 001 NOV 17, 1983 MAY DISC
>D> AB 330MG N62438 002 NOV 17, 1983 MAY DISC
>A> @ 330MG N62438 002 NOV 17, 1983 MAY DISC
HALOPERIDOL LACTATE
CONCENTRATE; ORAL
HALOPERIDOL
>D> AA ALPHARMA EQ 2MG BASE/ML N70318 001 APR 11, 1986 MAY DISC
>A> @ EQ 2MG BASE/ML N70318 001 APR 11, 1986 MAY DISC
HYDROCORTISONE
TABLET; ORAL
CORTEF
>D> PHARMACIA AND UPJOHN 5MG N08697 003 MAY CRLD
>A> + 5MG N08697 003 MAY CRLD
>D> BP 10MG N08697 001 MAY CRLD
>A> BP + 10MG N08697 001 MAY CRLD
>D> BP 20MG N08697 002 MAY CRLD
>A> BP + 20MG N08697 002 MAY CRLD
IDARUBICIN HYDROCHLORIDE
INJECTABLE; INJECTION
>A> IDAMYCIN
>D> + PHARMACIA AND UPJOHN 5MG/VIAL N50661 002 SEP 27, 1990 MAY CFTG
>A> AP + 5MG/VIAL N50661 002 SEP 27, 1990 MAY CFTG
>D> + 10MG/VIAL N50661 001 SEP 27, 1990 MAY CFTG
>A> AP + 10MG/VIAL N50661 001 SEP 27, 1990 MAY CFTG
>D> + 20MG/VIAL N50661 003 APR 25, 1995 MAY CFTG
>A> AP + 20MG/VIAL N50661 003 APR 25, 1995 MAY CFTG
>A> IDAMYCIN PFS
>D> + PHARMACIA AND UPJOHN 1MG/ML N50734 001 FEB 17, 1997 MAY CFTG
>A> AP + 1MG/ML N50734 001 FEB 17, 1997 MAY CFTG
>A> IDARUBICIN HCL
>A> AP GENSIA SICOR PHARMS 5MG/VIAL N65037 003 MAY 01, 2002 MAY NEWA
>A> AP 10MG/VIAL N65037 002 MAY 01, 2002 MAY NEWA
>A> AP 20MG/VIAL N65037 001 MAY 01, 2002 MAY NEWA
>A> IDARUBICIN HCL PFS
>A> AP GENSIA SICOR PHARMS 1MG/ML N65036 001 MAY 01, 2002 MAY NEWA
>A> IFOSFAMIDE
>A> INJECTABLE; INJECTION
>A> IFSOFAMIDE
>A> AM PHARM PARTNERS 1GM/VIAL N76078 001 MAY 28, 2002 MAY NEWA
>A> + 3GM/VIAL N76078 002 MAY 28, 2002 MAY NEWA
INDOMETHACIN
SUPPOSITORY; RECTAL
INDOCIN
>D> AB + MERCK 50MG N17814 001 AUG 13, 1984 MAY DISC
>A> @ 50MG N17814 001 AUG 13, 1984 MAY DISC
INDOMETHEGAN
>D> AB G AND W LABS 50MG N73314 001 AUG 31, 1992 MAY CRLD
>A> + 50MG N73314 001 AUG 31, 1992 MAY CRLD
LEVOTHYROXINE SODIUM
TABLET; ORAL
>A> NOVOTHYROX
>A> BX GENPHARM 0.025MG N21292 001 MAY 31, 2002 MAY NEWA
>A> BX 0.05MG N21292 002 MAY 31, 2002 MAY NEWA
>A> BX 0.075MG N21292 003 MAY 31, 2002 MAY NEWA
>A> BX 0.088MG N21292 004 MAY 31, 2002 MAY NEWA
>A> BX 0.1MG N21292 005 MAY 31, 2002 MAY NEWA
>A> BX 0.112MG N21292 006 MAY 31, 2002 MAY NEWA
>A> BX 0.125MG N21292 007 MAY 31, 2002 MAY NEWA
>A> BX 0.137MG N21292 008 MAY 31, 2002 MAY NEWA
>A> BX 0.15MG N21292 009 MAY 31, 2002 MAY NEWA
>A> BX 0.175MG N21292 010 MAY 31, 2002 MAY NEWA
>A> BX 0.2MG N21292 011 MAY 31, 2002 MAY NEWA
>A> BX + 0.3MG N21292 012 MAY 31, 2002 MAY NEWA
METAPROTERENOL SULFATE
SOLUTION; INHALATION
METAPROTERENOL SULFATE
>A> AN MORTON GROVE 0.4% N75586 001 MAY 30, 2002 MAY NEWA
>A> AN 0.6% N75586 002 MAY 30, 2002 MAY NEWA
METFORMIN HYDROCHLORIDE
TABLET; ORAL
METFORMIN HCL
>A> AB GENEVA PHARMS 500MG N75985 001 JAN 25, 2002 MAY CAHN
>A> AB 850MG N75985 002 JAN 25, 2002 MAY CAHN
>A> AB 1GM N75985 003 JAN 25, 2002 MAY CAHN
>D> AB GENEVA PHARMS TECH 500MG N75985 001 JAN 25, 2002 MAY CAHN
>D> AB 850MG N75985 002 JAN 25, 2002 MAY CAHN
>D> AB 1GM N75985 003 JAN 25, 2002 MAY CAHN
METHYLPREDNISOLONE
TABLET; ORAL
METHYLPREDNISOLONE
>A> AB GENEVA PHARMS 4MG N40194 001 OCT 31, 1997 MAY CAHN
>D> AB GENEVA PHARMS TECH 4MG N40194 001 OCT 31, 1997 MAY CAHN
MILRINONE LACTATE
INJECTABLE; INJECTION
>A> MILRINONE LACTATE
>A> AP ABBOTT EQ 1MG BASE/ML N75884 001 MAY 28, 2002 MAY NEWA
>A> AP AM PHARM PARTNERS EQ 1MG BASE/ML N75936 001 MAY 28, 2002 MAY NEWA
>A> AP BAXTER HLTHCARE CORP EQ 1MG BASE/ML N75852 001 MAY 28, 2002 MAY NEWA
>A> AP BEDFORD EQ 1MG BASE/ML N75660 001 MAY 28, 2002 MAY NEWA
>A> AP EQ 20MG /20ML (1MG/ML) N75660 002 MAY 28, 2002 MAY NEWA
>A> AP EQ 50MG /50ML (1MG/ML) N75660 003 MAY 28, 2002 MAY NEWA
>A> AP ESI LEDERLE EQ 1MG BASE/ML N75530 001 MAY 28, 2002 MAY NEWA
>A> AP FAULDING EQ 1MG BASE/ML N75830 001 MAY 28, 2002 MAY NEWA
>A> MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER
>A> AP ABBOTT EQ 20MG BASE/100ML N75885 001 MAY 28, 2002 MAY NEWA
>A> AP + EQ 40MG BASE/200ML N75885 002 MAY 28, 2002 MAY NEWA
>A> AP BAXTER HLTHCARE EQ 20MG BASE/100ML N75834 001 MAY 28, 2002 MAY NEWA
>A> AP EQ 40MG BASE/100ML N75834 002 MAY 28, 2002 MAY NEWA
>A> AP ESI LEDERLE EQ 20MG BASE/100ML N75510 001 MAY 28, 2002 MAY NEWA
>A> PRIMACOR
>D> + SANOFI SYNTHELABO EQ 1MG BASE/ML N19436 001 DEC 31, 1987 MAY CFTG
>A> AP + EQ 1MG BASE/ML N19436 001 DEC 31, 1987 MAY CFTG
>A> PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> + SANOFI SYNTHELABO EQ 20MG BASE/100ML N20343 003 AUG 09, 1994 MAY CFTG
>A> AP EQ 20MG BASE/100ML N20343 003 AUG 09, 1994 MAY CFTG
>A> AP + EQ 40MG BASE/100ML N20343 004 AUG 09, 1994 MAY CFTG
>D> EQ 40MG BASE/100ML N20343 004 AUG 09, 1994 MAY CFTG
NEOMYCIN SULFATE
SOLUTION; ORAL
>A> MYCIFRADIN
>D> + PHARMACIA AND UPJOHN EQ 87.5MG BASE/5ML N50285 001 MAY CFTG
>A> AA + EQ 87.5MG BASE/5ML N50285 001 MAY CFTG
>A> NEO-FRADIN
>A> AA PHARMATEK EQ 87.5MG BASE/5ML N65010 001 MAY 23, 2002 MAY NEWA
NITISINONE
CAPSULE; ORAL
ORFADIN
>D> R R REGISTRATIONS 2MG N21232 001 JAN 18, 2002 MAY CAHN
>D> 5MG N21232 002 JAN 18, 2002 MAY CAHN
>D> + 10MG N21232 003 JAN 18, 2002 MAY CAHN
>A> SWEDISH ORPHAN 2MG N21232 001 JAN 18, 2002 MAY CAHN
>A> 5MG N21232 002 JAN 18, 2002 MAY CAHN
>A> + 10MG N21232 003 JAN 18, 2002 MAY CAHN
NORETHINDRONE
TABLET; ORAL
NOR-QD
>D> + WATSON LABS 0.35MG N17060 001 MAY CAHN
>A> + WATSON LABS (UTAH) 0.35MG N17060 001 MAY CAHN
OXAPROZIN
TABLET; ORAL
OXAPROZIN
>A> AB IVAX PHARMS 600MG N75846 001 MAY 13, 2002 MAY NEWA
PACLITAXEL
INJECTABLE; INJECTION
PACLITAXEL
>A> AP ABBOTT 6MG/ML N76131 001 MAY 08, 2002 MAY NEWA
PAMIDRONATE DISODIUM
INJECTABLE; INJECTION
>A> PAMIDRONATE DISODIUM
>A> AP AESGEN 30MG/VIAL N75594 001 MAY 06, 2002 MAY NEWA
>A> AP 90MG/VIAL N75594 002 MAY 06, 2002 MAY NEWA
>A> AP AM PHARM PARTNERS 30MG/VIAL N75773 001 MAY 06, 2002 MAY NEWA
>A> AP 30MG /10ML(3MG/ML) N76207 001 MAY 17, 2002 MAY NEWA
>A> AP 90MG/VIAL N75773 002 MAY 06, 2002 MAY NEWA
>A> AP 90MG /10ML(9MG/ML) N76207 002 MAY 17, 2002 MAY NEWA
>D> AP BEDFORD 30MG /10ML(3MG/ML) N21113 001 MAR 04, 2002 MAY CDFR
>A> AP 30MG /10ML(3MG/ML) N21113 001 MAR 04, 2002 MAY CDFR
>D> AP + 90MG /10ML(9MG/ML) N21113 002 MAR 04, 2002 MAY CDFR
>A> AP + 90MG /10ML(9MG/ML) N21113 002 MAR 04, 2002 MAY CDFR
>D> AP GENSIA SICOR PHARMS 30MG /10ML(3MG/ML) N76153 001 MAR 27, 2002 MAY CDFR
>A> AP 30MG /10ML(3MG/ML) N76153 001 MAR 27, 2002 MAY CDFR
>D> AP 90MG /10ML(9MG/ML) N76153 002 MAR 27, 2002 MAY CDFR
>A> AP 90MG /10ML(9MG/ML) N76153 002 MAR 27, 2002 MAY CDFR
PENICILLIN V POTASSIUM
FOR SOLUTION; ORAL
PEN-VEE K
>D> AA WYETH AYERST EQ 125MG BASE/5ML N60007 001 MAY DISC
>A> @ EQ 125MG BASE/5ML N60007 001 MAY DISC
>D> AA EQ 250MG BASE/5ML N60007 002 MAY DISC
>A> @ EQ 250MG BASE/5ML N60007 002 MAY DISC
PROPRANOLOL HYDROCHLORIDE
TABLET; ORAL
PROPRANOLOL HCL
>D> AB LEDERLE 80MG N70128 001 JUL 30, 1985 MAY CAHN
>A> @ 80MG N70128 001 JUL 30, 1985 MAY CAHN
>D> AB PUREPAC PHARM 10MG N70814 001 NOV 03, 1986 MAY DISC
>A> @ 10MG N70814 001 NOV 03, 1986 MAY DISC
>D> AB 20MG N70815 001 NOV 03, 1986 MAY DISC
>A> @ 20MG N70815 001 NOV 03, 1986 MAY DISC
>D> AB 40MG N70816 001 NOV 03, 1986 MAY DISC
>A> @ 40MG N70816 001 NOV 03, 1986 MAY DISC
>D> AB 60MG N70817 001 NOV 03, 1986 MAY DISC
>A> @ 60MG N70817 001 NOV 03, 1986 MAY DISC
>D> AB 80MG N70757 001 NOV 03, 1986 MAY DISC
>A> @ 80MG N70757 001 NOV 03, 1986 MAY DISC
RABEPRAZOLE SODIUM
TABLET, DELAYED RELEASE; ORAL
ACIPHEX
>D> + EISAI 20MG N20973 002 AUG 19, 1999 MAY CAHN
>A> + EISAI MEDCL RES 20MG N20973 002 AUG 19, 1999 MAY CAHN
SULFAMETHOXAZOLE
TABLET; ORAL
GANTANOL
>D> + @ ROCHE 500MG N12715 002 MAY CTEC
>A> @ 500MG N12715 002 MAY CTEC
TETRACYCLINE HYDROCHLORIDE
TABLET; ORAL
SUMYCIN
>D> @ APOTHECON 50MG N61147 003 MAY CAHN
>D> @ 100MG N61147 002 MAY CAHN
>D> 250MG N61147 001 MAY CAHN
>D> + 500MG N61147 004 MAY CAHN
>A> @ PAR PHARM 50MG N61147 003 MAY CAHN
>A> @ 100MG N61147 002 MAY CAHN
>A> 250MG N61147 001 MAY CAHN
>A> + 500MG N61147 004 MAY CAHN
TORSEMIDE
TABLET; ORAL
>A> DEMADEX
>D> ROCHE 5MG N20136 001 AUG 23, 1993 MAY CFTG
>A> AB 5MG N20136 001 AUG 23, 1993 MAY CFTG
>D> 10MG N20136 002 AUG 23, 1993 MAY CFTG
>A> AB 10MG N20136 002 AUG 23, 1993 MAY CFTG
>D> + 20MG N20136 003 AUG 23, 1993 MAY CFTG
>A> AB + 20MG N20136 003 AUG 23, 1993 MAY CFTG
>D> 100MG N20136 004 AUG 23, 1993 MAY CFTG
>A> AB 100MG N20136 004 AUG 23, 1993 MAY CFTG
>A> TORSEMIDE
>A> AB TEVA 5MG N76110 001 MAY 14, 2002 MAY NEWA
>A> AB 10MG N76110 002 MAY 14, 2002 MAY NEWA
>A> AB 20MG N76110 003 MAY 14, 2002 MAY NEWA
>A> AB 100MG N76110 004 MAY 14, 2002 MAY NEWA
>A> TREPROSTINIL SODIUM
>A> INJECTABLE; SUBCUTANEOUS
>A> REMODULIN
>A> UNITED THERAP 1MG/ML N21272 001 MAY 21, 2002 MAY NEWA
>A> 2.5MG/ML N21272 002 MAY 21, 2002 MAY NEWA
>A> 5MG/ML N21272 003 MAY 21, 2002 MAY NEWA
>A> + 10MG/ML N21272 004 MAY 21, 2002 MAY NEWA
UROFOLLITROPIN
INJECTABLE; INTRAMUSCULAR, SUBCUTANEOUS
>A> BRAVELLE
>A> BX + FERRING 75 IU/VIAL N21289 001 MAY 06, 2002 MAY NEWA
INJECTABLE; SUBCUTANEOUS
>A> FERTINEX
>D> + SERONO 75 IU/AMP N19415 005 AUG 23, 1996 MAY CTEC
>A> BX + 75 IU/AMP N19415 005 AUG 23, 1996 MAY CTEC
VENLAFAXINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
EFFEXOR XR
>D> + WYETH AYERST EQ 37.5MG BASE N20699 001 OCT 20, 1997 MAY CRLD
>A> EQ 37.5MG BASE N20699 001 OCT 20, 1997 MAY CRLD
>D> + EQ 150MG BASE N20699 004 OCT 20, 1997 MAY CRLD
>A> EQ 150MG BASE N20699 004 OCT 20, 1997 MAY CRLD
>A> VORICONAZOLE
>A> INJECTABLE; IV (INFUSION)
>A> VFEND
>A> + PFIZER 200MG/VIAL N21267 001 MAY 24, 2002 MAY NEWA
>A> TABLET; ORAL
>A> PFIZER 50MG N21266 001 MAY 24, 2002 MAY NEWA
>A> + 200MG N21266 002 MAY 24, 2002 MAY NEWA
IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
>A> CAPSULE; ORAL
>A> ADVIL COLD AND SINUS
>A> WYETH CONS 200MG;30MG N21374 001 MAY 30, 2002 MAY NEWA
PSEUDOEPHEDRINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
SUDAFED 12 HOUR
>A> + WARNER LAMBERT 120MG N73585 001 OCT 31, 1991 MAY CAHN
>D> + WARNER WELLCOME 120MG N73585 001 OCT 31, 1991 MAY CAHN
Last update: July 15, 2005 |
|
